Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Ganter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|January 5, 2008
Emerging applications of network and pathway analysis in drug discovery and developmentBrigitte Ganter, Craig N Giroux
Molecular Cancer|November 4, 2006
Myb proteins inhibit fibroblast transformation by v-RelShu-Ling Fu, Brigitte Ganter, Joseph S Lipsick
Pharmacogenomics|December 25, 2007
Pathway analysis tools and toxicogenomics reference databases for risk assessmentBrigitte Ganter, Nadine Zidek, Philip R Hewitt, et al.
Pharmacogenomics|October 24, 2006
Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix databaseBrigitte Ganter, Ronald D Snyder, Donald N Halbert, et al.
Blood|October 3, 2013
Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemiaMajed J Dasouki, Syed K Rafi, Adam J Olm-Shipman, et al.
Nucleic Acids Research|December 27, 2005
Use of a mixed tissue RNA design for performance assessments on multiple microarray formatsKarol L Thompson, Barry A Rosenzweig, P Scott Pine, et al.
Journal of Biotechnology|July 12, 2005
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and actionBrigitte Ganter, Stuart Tugendreich, Cecelia I Pearson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|January 5, 2008
Emerging applications of network and pathway analysis in drug discovery and developmentBrigitte Ganter, Craig N Giroux
Molecular Cancer|November 4, 2006
Myb proteins inhibit fibroblast transformation by v-RelShu-Ling Fu, Brigitte Ganter, Joseph S Lipsick
Pharmacogenomics|December 25, 2007
Pathway analysis tools and toxicogenomics reference databases for risk assessmentBrigitte Ganter, Nadine Zidek, Philip R Hewitt, et al.
Pharmacogenomics|October 24, 2006
Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix databaseBrigitte Ganter, Ronald D Snyder, Donald N Halbert, et al.
Blood|October 3, 2013
Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemiaMajed J Dasouki, Syed K Rafi, Adam J Olm-Shipman, et al.
Nucleic Acids Research|December 27, 2005
Use of a mixed tissue RNA design for performance assessments on multiple microarray formatsKarol L Thompson, Barry A Rosenzweig, P Scott Pine, et al.
Journal of Biotechnology|July 12, 2005
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and actionBrigitte Ganter, Stuart Tugendreich, Cecelia I Pearson, et al.
Pageof 1